We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Rat Center to Serve as Worldwide Resource

By Biotechdaily staff writers
Posted on 21 May 2002
A Rat Resource and Research Center (RRRC) at the University of Missouri (USA) will serve as a resource for investigators worldwide to further the study of rat models for biomedical research. More...


The RRRC will import, cryopreserve, produce, and distribute high-quality laboratory rats.
The center's inventory will include various inbred, hybrid, and genetically modified rats for use in biomedical research. These mutant rat strains will be provided to the RRRC by investigators who have derived them but lack the resources to cryopreserve and broadly distribute them. Currently, there are many more mutant strains than there is capacity to make them available in pathogen-free form to researchers. The RRRC will serve as a centralized source of information on the availability of specific rat lines and also as a source of the animals. Added services include genotyping, phenotyping, and testing for and eliminating pathogens.

The center was formed by researchers from the University of Missouri, the Indiana University School of Medicine, and Northwestern University Medical School with a US$6.7 million grant from the U.S. National Center for Research Resources (NCRR) and the US National Heart, Lung, and Blood Institute.

"The mouse and rate genomes are currently being mapped and sequenced, and this activity is expected to facilitate derivation of even more mutant rats in the near future,” said Judith Vaitukaitis, M.D., director of the NCRR.


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
See-Saw Rocking Shaker
SH-200D-S-L
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.